chr22-39225792-G-T
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_002608.4(PDGFB):c.657C>A(p.Pro219Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00282 in 1,614,018 control chromosomes in the GnomAD database, including 111 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.015 ( 59 hom., cov: 32)
Exomes 𝑓: 0.0015 ( 52 hom. )
Consequence
PDGFB
NM_002608.4 synonymous
NM_002608.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.288
Genes affected
PDGFB (HGNC:8800): (platelet derived growth factor subunit B) This gene encodes a member of the protein family comprised of both platelet-derived growth factors (PDGF) and vascular endothelial growth factors (VEGF). The encoded preproprotein is proteolytically processed to generate platelet-derived growth factor subunit B, which can homodimerize, or alternatively, heterodimerize with the related platelet-derived growth factor subunit A. These proteins bind and activate PDGF receptor tyrosine kinases, which play a role in a wide range of developmental processes. Mutations in this gene are associated with meningioma. Reciprocal translocations between chromosomes 22 and 17, at sites where this gene and that for collagen type 1, alpha 1 are located, are associated with dermatofibrosarcoma protuberans, a rare skin tumor. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.63).
BP6
Variant 22-39225792-G-T is Benign according to our data. Variant chr22-39225792-G-T is described in ClinVar as [Benign]. Clinvar id is 777710.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-39225792-G-T is described in Lovd as [Likely_benign].
BP7
Synonymous conserved (PhyloP=0.288 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0518 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PDGFB | NM_002608.4 | c.657C>A | p.Pro219Pro | synonymous_variant | 6/7 | ENST00000331163.11 | NP_002599.1 | |
PDGFB | NM_033016.3 | c.612C>A | p.Pro204Pro | synonymous_variant | 6/7 | NP_148937.1 | ||
PDGFB | XM_047441393.1 | c.564C>A | p.Pro188Pro | synonymous_variant | 6/7 | XP_047297349.1 | ||
PDGFB | XM_047441394.1 | c.564C>A | p.Pro188Pro | synonymous_variant | 6/7 | XP_047297350.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PDGFB | ENST00000331163.11 | c.657C>A | p.Pro219Pro | synonymous_variant | 6/7 | 1 | NM_002608.4 | ENSP00000330382.6 | ||
PDGFB | ENST00000381551.8 | c.612C>A | p.Pro204Pro | synonymous_variant | 6/7 | 5 | ENSP00000370963.4 |
Frequencies
GnomAD3 genomes AF: 0.0152 AC: 2309AN: 152160Hom.: 58 Cov.: 32
GnomAD3 genomes
AF:
AC:
2309
AN:
152160
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00386 AC: 970AN: 251272Hom.: 21 AF XY: 0.00285 AC XY: 387AN XY: 135824
GnomAD3 exomes
AF:
AC:
970
AN:
251272
Hom.:
AF XY:
AC XY:
387
AN XY:
135824
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00153 AC: 2231AN: 1461740Hom.: 52 Cov.: 31 AF XY: 0.00124 AC XY: 902AN XY: 727170
GnomAD4 exome
AF:
AC:
2231
AN:
1461740
Hom.:
Cov.:
31
AF XY:
AC XY:
902
AN XY:
727170
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0152 AC: 2315AN: 152278Hom.: 59 Cov.: 32 AF XY: 0.0148 AC XY: 1101AN XY: 74436
GnomAD4 genome
AF:
AC:
2315
AN:
152278
Hom.:
Cov.:
32
AF XY:
AC XY:
1101
AN XY:
74436
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
41
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jun 01, 2019 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 26, 2024 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at